Navigation Links
Fact and friction: Putting election-year stem cell claims under the microscope

Madison, Wis. - So, it has come to this: A degree in molecular biology will be required of anyone wishing to vote in Wisconsin's Nov. 7 elections.

Or perhaps it only seems so in light of 2006 campaign year claims and counter-claims swirling around the "wedge issue" of human embryonic stem cell research. To assist those who won't complete t......

Full article >>> of older human ES lines; most recently, he voted to uphold President Bush's veto of a bill that would have allowed federal investment in new lines.

Basic scientific research in the United States rarely occurs without federal funding; venture capitalists and angel investors won't fund something that is years from the market. A few private foundations are investing in stem cell research, an......

Full article >>> ars.

The vast majority of scientists say it's not a question of "either" human embryonic stem cell research "or" adult stem cell research, but a matter of conducting both and comparing notes.

Mark Green says he does not believe "anyone should be allowed to clone a human being Jim Doyle does." Is it true that Doyle wants to clone a person - perhaps even a campaign contri......

Full article >>> ect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or opinions expressed herein.
......

Full article >>>
'"/>


Source:wistechnology.com By Tom Still 08/07/06


Related biology technology :

1. Putting spam back in the can wont be all that easy
2. MailFoundry claims worlds fastest anti-spam filter
3. Got Game makes big claims; can 90 million people think the same?
4. GenTel claims $900,000 in federal grants this year for biochip research
5. Governor Proclaims November 1-7 Health Science and Technology Recognition Week
6. CIO Leadership Series: Deb Rislow, Gundersen Lutheran
7. Landmark patent law under attack, Bayh says
8. Start-ups "down under" not captivated by Web 2.0
9. Protein lab could prosper under new owner
10. Leadership insights from co-founder of Yesmail
11. U.S. health system could undermine EHR progress
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... YORK , Feb. 20, 2017 This report ... by the following Product Types: Xylanase, Amylase, Cellulase, and Others. ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the period ...
(Date:2/20/2017)... ... February 20, 2017 , ... PuraCath Medical, ... with peritoneal dialysis, announced today that it has published the result of its ... Peritoneal Dialysis International (PDI), the official Journal of the International Society for ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf ... Poster legt metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... ... Yoav Peretz , Scientific Director bei ImmuneCarta, einen ... zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a ... announce development of a novel system for quantitative ... with the University of Rochester (NY, USA) and ... The new system is able to accurately quantify ... HER2 (Human epidermal growth factor receptor-2) in clinical ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):